Vanguard Group Inc Ab Cellera Biologics Inc. Transaction History

Vanguard Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$3.91 - $5.93 $51,267 - $77,754	13,112 New	13,112 $74,000
Q1 2023 May 15, 2023	BUY	$7.31 - $11.18 $92,084 - $140,834	12,597 Added 1.29%	989,154 $7.46 Million
Q4 2022 Feb 10, 2023	BUY	$9.48 - $14.52 $925,864 - $1.42 Million	97,665 Added 11.11%	976,557 $9.89 Million
Q3 2022 Nov 14, 2022	SELL	$9.2 - $13.68 $140,594 - $209,057	-15,282 Reduced 1.71%	878,892 $8.69 Million
Q2 2022 Aug 12, 2022	BUY	$5.72 - $10.65 $5.11 Million - $9.52 Million	894,174 New	894,174 $9.52 Million

155

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $807M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.